A hyper-ferritinemia syndrome evolving in recurrent macrophage activation syndrome, as an onset of amyopathic juvenile dermatomyositis: a challenging clinical case in light of the current diagnostic criteria

Autoimmun Rev. 2014 Nov;13(11):1142-8. doi: 10.1016/j.autrev.2014.05.009. Epub 2014 May 29.

Abstract

Juvenile dermatomyositis is an immune-mediated inflammatory multi-system disease involving mainly striated muscles and skin. Typical dermatological features are fundamental to establish the diagnosis, especially whenever the myopathy is very mild or absent, as it occurs in the form called as amyopathic juvenile dermatomyositis. Sometimes, systemic rheumatic diseases can develop a hyperferritinemia syndrome characterized by hemophagocytosis, namely macrophage activation syndrome, which represents a severe and life-threatening complication. Here, we describe a complex clinical history characterized by a hyper-ferritinemia syndrome after infectious mononucleosis, leading to recurrent episodes of macrophage activation syndrome. Finally, the late onset of several skin changes brought to a diagnosis of amyopathic juvenile dermatomyositis.

Keywords: Epstein–Barr virus; Hyperferritinemia; Juvenile dermatomyositis; Macrophage activation syndrome.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Age of Onset
  • Dermatomyositis / diagnosis*
  • Humans
  • Macrophage Activation Syndrome / diagnosis*
  • Recurrence
  • Skin / pathology

Supplementary concepts

  • Amyopathic dermatomyositis